Quotient Sciences

two jiggsaw puzzles connected with drawn hands shaking on the two puzzles
Manufacturing

CDMO Quotient extends Ipsen supply deal for rare disease drug

Quotient Sciences extended its deal with Ipsen to manufacture the only medication approved by the FDA to treat fibrodysplasia ossificans progressiva.
Joseph Keenan Mar 2, 2026 11:00am
Alnwick Castle and the Lions Bridge

Quotient Sciences casts $8.7M spell over new Alnwick facility

Sep 2, 2021 9:55am
Helsinki Finland

Nanoform to test nanoformed drug in humans before year is out

Oct 22, 2020 7:45am
Handshake

Charles River sells CDMO QS Pharma to Quotient Clinical

Feb 16, 2017 8:13am